Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population

Objectives To determine contemporary population estimates of the prevalence of cardiac permanent pacemaker (PPM) insertions. Methods A population-based observational study using linked hospital morbidity and death registry data from Western Australia (WA) to identify all incident cases of PPM insertion for adults aged 18 years or older. Prevalence rates were calculated by age and sex for the years 1995–2009 for the WA population. Results There were 9782 PPMs inserted during 1995–2009. Prevalence rose across the study period, exceeding 1 in 50 among people aged 75 or older from 2005. This was underpinned by incidence rates which rose with age, being highest in those 85 years or older; over 500/100 000 for men throughout, and over 200/100 000 for women. Rates for patients over 75 were more than double the rates for those aged 65–74 years. Women were around 40% of cases overall. The use of dual-chamber and triple-chamber pacing increased across the study period. A cardiac resynchronisation defibrillator was implanted for 58% of patients treated with cardiac resynchronisation therapy. Conclusions Rates of insertion and prevalence of PPM continue to rise with the ageing population in WA. As equilibrium has probably not been reached, the demand for pacing services in similarly well-developed economies is likely to continue to grow.

[1]  Joseph E. Marine,et al.  Epidemiology of arrhythmias and conduction disorders in older adults. , 2012, Clinics in geriatric medicine.

[2]  H. Mond.  The World Survey of Cardiac Pacing and Cardioverter Defibrillators: Calendar Year 1997 ‐ Asian Pacific, Middle East, South America, and Canada , 2001, Pacing and clinical electrophysiology : PACE.

[3]  J. Ferrer,et al.  Registro Español de Marcapasos. V Informe Oficial de la Sección de Estimulación Cardiaca de la Sociedad Española de Cardiología (2007) , 2008 .

[4]  J. Finn,et al.  A validation study: how effective is the Hospital Morbidity Data as a surveillance tool for heart failure in Western Australia? , 2008, Australian and New Zealand journal of public health.

[5]  L. Padeletti,et al.  Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  M. J. Sancho Tello,et al.  Spanish Pacemaker Registry. Fifth official report of the Spanish Society of Cardiology Working Group on Cardiac Pacing (2007). , 2008, Revista espanola de cardiologia.

[7]  K. Jamrozik,et al.  Mobile Australians: a moving target for epidemiologists , 2000, The Medical journal of Australia.

[8]  É. Marijon,et al.  Implantation and patient profiles for pacemakers and cardioverter-defibrillators in France (2008-2009). , 2011, Archives of cardiovascular diseases.

[9]  P. Vardas,et al.  The World Survey of Cardiac Pacing and Implantable Cardioverter Defibrillators: Calendar Year 1997 ‐ Europe , 2001, Pacing and clinical electrophysiology : PACE.

[10]  E. Epstein,et al.  Pulmonary ossific nodule formation in the absence of mitral valve disease , 1963 .

[11]  Chunliu Zhan,et al.  Cardiac Device Implantation in the United States from 1997 through 2004: A Population-based Analysis , 2007, Journal of General Internal Medicine.

[12]  M. Hobbs,et al.  Use and long-term outcomes of implantable cardioverter-defibrillators, 1990 to 2009. , 2013, American heart journal.

[13]  K. Fernow.  New York , 1896, American Potato Journal.

[14]  C. Valzania,et al.  Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  G. Gregoratos,et al.  MANAGEMENT OF ATRIAL FIBRILLATION, VENTRICULAR ARRHYTHMIAS AND PACEMAKERS IN OLDER PERSONS: Permanent Pacemakers in Older Persons , 1999 .

[16]  Hugo Ector,et al.  Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association , 2007 .

[17]  Lisa Mielniczuk,et al.  Reasons for escalating pacemaker implants. , 2006, The American journal of cardiology.

[18]  G. Mcnicoll.  World Population Ageing 1950-2050. , 2002 .

[19]  A. Proclemer,et al.  Trend of the main clinical characteristics and pacing modality in patients treated by pacemaker: data from the Italian Pacemaker Registry for the quinquennium 2003-07. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  T. Gross,et al.  The epidemiology of pacemaker implantation in the United States. , 1995, Public health reports.

[21]  P. Lambiase,et al.  An 8-year single-centre experience of cardiac resynchronisation therapy: procedural success, early and late complications, and left ventricular lead performance. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[22]  H. Mond,et al.  The World Survey of Cardiac Pacingand Cardioverter‐Defibrillators: Calendar Year 2005 An International Cardiac Pacing andElectrophysiology Society (ICPES) project , 2008, Pacing and clinical electrophysiology : PACE.

[23]  A. J. Bass,et al.  Population‐based linkage of health records in Western Australia: development of a health services research linked database , 1999, Australian and New Zealand journal of public health.

[24]  C. Morillo,et al.  The World Survey of Cardiac Pacing and Cardioverter Defibrillators: Calendar Year 2001 , 2004, Pacing and clinical electrophysiology : PACE.

[25]  A. Green,et al.  The Epidemiology of Pacemaker Implantations in Fyn County, Denmark , 1991, Pacing and clinical electrophysiology : PACE.

[26]  P. Vardas,et al.  Tracing the European course of cardiac resynchronization therapy from 2006 to 2008. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[27]  G. Mensah,et al.  Epidemiology of pacemaker procedures among Medicare enrollees in 1990, 1995, and 2000. , 2005, The American journal of cardiology.

[28]  N. Grassly,et al.  United Nations Department of Economic and Social Affairs/population Division , 2022 .

[29]  H. Mond,et al.  The 11th World Survey of Cardiac Pacing and Implantable Cardioverter‐Defibrillators: Calendar Year 2009–A World Society of Arrhythmia's Project , 2011, Pacing and clinical electrophysiology : PACE.

[30]  L. Baddour,et al.  Temporal trends in permanent pacemaker implantation: a population-based study. , 2008, American heart journal.

[31]  Daniel R. Frisch,et al.  Implantation Trends and Patient Profiles for Pacemakers and Implantable Cardioverter Defibrillators in the United States: 1993–2006 , 2010, Pacing and clinical electrophysiology : PACE.

[32]  H. Mond,et al.  The Australian and New Zealand cardiac pacing and implantable cardioverter-defibrillator survey: calendar year 2005. , 2004, Heart, lung & circulation.